ATLANTA, Jan. 5, 2016 /PRNewswire/ -- Global Genomics Group ("G3") announced that it has entered into a research collaboration with Sanofi (EURONEXT: SAN; NYSE: SNY) to identify new signaling pathways and targets involved in the etiology of coronary artery disease.

Read the full article here:

http://www.prnewswire.com/news-releases/global-genomics-group-g3-partners-with-sanofi-to-identify-new-signaling-pathways-in-atherosclerotic-cardiovascular-diseases-300195426.html